1
40
1
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
Backlog
URL Address
<a href="http://doi.org/10.1080/10673220601082869" target="_blank" rel="noreferrer">http://doi.org/10.1080/10673220601082869</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Empirical evidence for the use of lithium and anticonvulsants in children with psychiatric disorders
Publisher
An entity responsible for making the resource available
Harvard Review Of Psychiatry
Date
A point or period of time associated with an event in the lifecycle of the resource
2006
Subject
The topic of the resource
Child; Humans; Anticonvulsants/therapeutic use; Empirical Research; Amines/therapeutic use; Cyclohexanecarboxylic Acids/therapeutic use; gamma-Aminobutyric Acid/therapeutic use; Antimanic Agents/therapeutic use; Carbamazepine/analogs & derivatives/therapeutic use; Drug Therapy/statistics & numerical data; Fructose/analogs & derivatives/therapeutic use; Lithium Carbonate/therapeutic use; Mental Disorders/drug therapy/epidemiology; Triazines/therapeutic use; Valproic Acid/therapeutic use
Creator
An entity primarily responsible for making the resource
Lopez-Larson M; Frazier JA
Description
An account of the resource
BACKGROUND: The use of psychotropic medications-in particular, mood stabilizers--in youths with psychiatric illness has grown. There are trends toward polypharmacy and the increased use of newer mood stabilizers in youths with psychiatric illness despite a paucity of studies examining the short- and long-term efficacy and safety of these agents in the pediatric population. METHOD: PubMed was used to identify peer-reviewed publications from the past 30 years (January 1975 to August 2005) studying lithium and anticonvulsants in youths with psychiatric illness. RESULTS: Evidence supporting the use of lithium and valproate in the treatment of juvenile bipolar disorder and reactive aggression has grown. Evidence for the use of other anticonvulsants in youths with psychiatric illness is sparse. Side effects from lithium and anticonvulsants are typically mild to moderate. Data are accumulating in regard to the longer-term safety of lithium and DVPX in the juvenile psychiatric population. Although data in regard to the newer anticonvulsants are limited, they may have more desirable side-effect profiles. CONCLUSION: Double-blind, placebo-controlled trials of lithium and anticonvulsants are greatly needed as clinical use of these agents has risen without sufficient evidence supporting their efficacy in the pediatric population.
2006
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1080/10673220601082869" target="_blank" rel="noreferrer">10.1080/10673220601082869</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
The nature or genre of the resource
Journal Article
2006
Amines/therapeutic use
Anticonvulsants/therapeutic use
Antimanic Agents/therapeutic use
Backlog
Carbamazepine/analogs & derivatives/therapeutic use
Child
Cyclohexanecarboxylic Acids/therapeutic use
Drug Therapy/statistics & numerical data
Empirical Research
Frazier JA
Fructose/analogs & derivatives/therapeutic use
gamma-Aminobutyric Acid/therapeutic use
Harvard Review Of Psychiatry
Humans
Journal Article
Lithium Carbonate/therapeutic use
Lopez-Larson M
Mental Disorders/drug therapy/epidemiology
Triazines/therapeutic use
Valproic Acid/therapeutic use